The substance is researched within the patent literature for its anxiolytic Qualities and lowered sedative, hypnotic, and ataxic facet-effects, but it does not appear to be licensed for clinical use. ?ukasik-G?ebocka et al There are various worries regarding diagnosing and managing DBZ use, e